FDA Expands Semaglutide Use for CV, Kidney Risks in T2D, CKD Kyle Munz Key Takeaways Semaglutide is now approved for T2D patients with CKD, reducing cardiovascular and kidney disease risks
Some excellent sources include: Beef and poultry Fish and seafood Eggs Dairy products Plant-based sources like beans, lentils, and spinach For those with increased needs or specific health goals, supplementation may be beneficial
You may also experience some injection site reactions, such as redness, swelling, or pain
Common side effects and contraindications (bullet list): Mild injection-site redness, bruising Increased hunger, flushing, water retention Headache, dizziness, nausea Temporary joint discomfort Contraindications: active cancer, uncontrolled diabetes, pregnancy, certain cardiac conditions Long-Term Effects Long-term use of CJC-1295, either alone or in combination with peptides such as Ipamorelin, may cause persistent changes in hormones impacting reproductive health and aging
In younger patients and more mild cases where the skin elasticity remains reasonably strong, fillers tend to work better, Byrne explained